Omron Healthcare - Patient Monitoring Solutions/Service Company

Omron Healthcare: Going for Zero

Follow Omron Healthcare on :

Ranndy Kellogg, President & CEO, Omron HealthcareRanndy Kellogg, President & CEO, Omron Healthcare
High blood pressure is known as the “silent killer” that may have zero warning signs or symptoms. To make matters worse, people are often unaware of the presence of such adversities, despite doctors’ persistent emphasis on monitoring blood pressure levels regularly. According to guidelines set by the American Heart Association (AHA) and the American College of Cardiology (ACC), about 103 million adults in the U.S. have high blood pressure, and only about half of these people have it under control. This prevailing condition increases the risk of heart attack and stroke, leading to severe illness, disability, and lower quality of life. To mitigate such problems, Omron Healthcare offers a multitude of wearable and upper arm blood pressure monitors for measuring hypertension and to help people change their lifestyle to prevent heart attacks and strokes. “Our mission is to eliminate various health concerns related to blood pressure, and bringing it them down to zero,” states Ranndy Kellogg, president and CEO of Omron Healthcare.

Omron Healthcare provides a wide range of products to track blood pressure and enable users to understand their health condition. Its latest monitor, HeartGuide–the first wearable blood pressure monitor—allows users to measure blood pressure with clinical accuracy, and observe sleep quality, track steps, and daily activity levels. The firm also offers a mobile application— OMRON Connect—that pairs with Omron blood pressure monitors and stores records of blood pressure readings in a HIPAA-compliant cloud, which can then be shared with family and physicians. Omron Healthcare’s new HeartAdvisor application provides insights into users’ hypertension data and helps users better understand how their lifestyle habits affect their numbers. This causes a sense of self-contemplation among patients, probing them to reassess lifestyle and strive for a behavioral change.

Our HeartAdvisor application serves as a health coach by initiating a thought process and making that initial leap for lifestyle change such as diet control, exercise, and more

“Our HeartAdvisior app serves as a health coach by initiating a thought process and taking that initial leap for lifestyle change such as diet control, exercise, and more,” adds Kellogg. The firm’s solutions can be paired with Amazon Alexa to enable voice assistance for obtaining blood pressure readings and other information sets. Omron Healthcare is further working with healthcare providers to enhance HeartAdvisor’s capability and enable physicians to automatically gather their patients’ hypertension information in real-time.

Omron Healthcare has piloted several initiatives pertaining to mobile monitoring of blood pressure and has helped consumers reduce their risk of heart attack and stroke and facilitate more proactive health conversations between doctors and patients. One of the many success stories scripted by the company is that of one of its influencers, who discovered that she had hypertension. Using the firm’s EVOLV upper arm blood pressure monitor, the influencer monitored her blood pressure patterns and identified that the readings were at the highest during office hours. In the wake of this, she accepted a job offer that had low-stress conditions and subsequently witnessed a healthier blood pressure reading.

Such counter measures not only help people in need but also organizations in spreading awareness about heart attacks and strokes. Omron further collaborates with healthcare providers and understands their requirements to diagnose patients better. Such associations have assisted Omron Healthcare in developing products that can monitor both electrocardiogram (EKG) and blood pressure simultaneously, like the newly launched Complete monitor. “We have many products in our pipeline that will help doctors collect their patients’ information and make an informed decision while treating them,” concludes Kellogg.